Works by Bargou, Ralf C.


Results: 33
    1

    Characterization and root cause analysis of immunogenicity to pasotuxizumab (AMG 212), a prostate-specific membrane antigen-targeting bispecific T-cell engager therapy.

    Published in:
    Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1261070
    By:
    • Penny, Hweixian Leong;
    • Hainline, Kelly;
    • Theoharis, Nathaniel;
    • Bin Wu;
    • Christian Brandl;
    • Webhofer, Christian;
    • McComb, Mason;
    • Wittemer-Rump, Sabine;
    • Koca, Gökben;
    • Stienen, Sabine;
    • Bargou, Ralf C.;
    • Hummel, Horst-Dieter;
    • Loidl, Wolfgang;
    • Grüllich, Carsten;
    • Eggert, Tobias;
    • Tran, Ben;
    • Mytych, Daniel T.
    Publication type:
    Article
    2

    Characterization and root cause analysis of immunogenicity to pasotuxizumab (AMG 212), a prostate-specific membrane antigen-targeting bispecific T-cell engager therapy.

    Published in:
    Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1261070
    By:
    • Penny, Hweixian Leong;
    • Hainline, Kelly;
    • Theoharis, Nathaniel;
    • Bin Wu;
    • Brandl, Christian;
    • Webhofer, Christian;
    • McComb, Mason;
    • Wittemer-Rump, Sabine;
    • Koca, Gökben;
    • Stienen, Sabine;
    • Bargou, Ralf C.;
    • Hummel, Horst-Dieter;
    • Loidl, Wolfgang;
    • Grüllich, Carsten;
    • Eggert, Tobias;
    • Tran, Ben;
    • Mytych, Daniel T.
    Publication type:
    Article
    3

    Tumour stage distribution and survival of malignant melanoma in Germany 2002-2011.

    Published in:
    BMC Cancer, 2016, v. 16, p. 1, doi. 10.1186/s12885-016-2963-0
    By:
    • Schoffer, Olaf;
    • Schülein, Stefanie;
    • Arand, Gerlinde;
    • Arnholdt, Hans;
    • Baaske, Dieter;
    • Bargou, Ralf C.;
    • Becker, Nikolaus;
    • Beckmann, Matthias W.;
    • Bodack, Yves;
    • Böhme, Beatrix;
    • Bozkurt, Tayfun;
    • Breitsprecher, Regine;
    • Buchali, Andre;
    • Burger, Elke;
    • Burger, Ulrike;
    • Dommisch, Klaus;
    • Elsner, Gudrun;
    • Fernschild, Karin;
    • Flintzer, Ulrike;
    • Funke, Uwe
    Publication type:
    Article
    4
    5
    6

    Curative outcomes following blinatumomab in adults with minimal residual disease B-cell precursor acute lymphoblastic leukemia.

    Published in:
    Leukemia & Lymphoma, 2020, v. 61, n. 11, p. 2665, doi. 10.1080/10428194.2020.1780583
    By:
    • Gökbuget, Nicola;
    • Zugmaier, Gerhard;
    • Dombret, Hervé;
    • Stein, Anthony;
    • Bonifacio, Massimiliano;
    • Graux, Carlos;
    • Faul, Christoph;
    • Brüggemann, Monika;
    • Taylor, Kate;
    • Mergen, Noemi;
    • Reichle, Albrecht;
    • Horst, Heinz-August;
    • Havelange, Violaine;
    • Topp, Max S.;
    • Bargou, Ralf C.
    Publication type:
    Article
    7
    8
    9
    10

    Anti-myeloma activity of the novel 2-aminothienopyrimidine Hsp90 inhibitor NVP-BEP800.

    Published in:
    British Journal of Haematology, 2009, v. 147, n. 3, p. 319, doi. 10.1111/j.1365-2141.2009.07852.x
    By:
    • Stühmer, Thorsten;
    • Chatterjee, Manik;
    • Grella, Evelyn;
    • Seggewiss, Ruth;
    • Langer, Christian;
    • Müller, Sabine;
    • Schoepfer, Joseph;
    • Garcia-Echeverria, Carlos;
    • Quadt, Cornelia;
    • Jensen, Michael R.;
    • Einsele, Hermann;
    • Bargou, Ralf C.
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    PI3K-dependent multiple myeloma cell survival is mediated by the PIK3 CA isoform.

    Published in:
    British Journal of Haematology, 2014, v. 166, n. 4, p. 529, doi. 10.1111/bjh.12920
    By:
    • Hofmann, Claudia;
    • Stühmer, Thorsten;
    • Schmiedl, Nadine;
    • Wetzker, Reinhard;
    • Mottok, Anja;
    • Rosenwald, Andreas;
    • Langer, Christian;
    • Zovko, Josip;
    • Chatterjee, Manik;
    • Einsele, Hermann;
    • Bargou, Ralf C.;
    • Steinbrunn, Torsten
    Publication type:
    Article
    23
    24
    25
    26
    27
    28

    Functional characterization of the RAL-dependent survival pathway in multiple myeloma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e138, doi. 10.1016/j.clml.2019.09.230
    By:
    • Seibold, Marcel;
    • Stühmer, Thorsten;
    • Mottok, Anja;
    • Scholz, Claus;
    • Chatterjee, Manik;
    • Leich, Ellen;
    • Barrio, Santiago;
    • Kortüm, K.M.;
    • Schlosser, Andreas;
    • Rosenwald, Andreas;
    • Einsele, Hermann;
    • Bargou, Ralf C.;
    • Steinbrunn, Torsten
    Publication type:
    Article
    29
    30
    31
    32
    33

    On-target restoration of a split T cell-engaging antibody for precision immunotherapy.

    Published in:
    Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-13196-0
    By:
    • Banaszek, Agnes;
    • Bumm, Thomas G. P.;
    • Nowotny, Boris;
    • Geis, Maria;
    • Jacob, Kim;
    • Wölfl, Matthias;
    • Trebing, Johannes;
    • Kucka, Kirstin;
    • Kouhestani, Dina;
    • Gogishvili, Tea;
    • Krenz, Bastian;
    • Lutz, Justina;
    • Rasche, Leo;
    • Hönemann, Dirk;
    • Neuweiler, Hannes;
    • Heiby, Julia C.;
    • Bargou, Ralf C.;
    • Wajant, Harald;
    • Einsele, Hermann;
    • Riethmüller, Gert
    Publication type:
    Article